Community prescribing and resistant Streptococcus pneumoniae. - Wikidata - awgldk - TriplyDB

Community prescribing and resistant Streptococcus pneumoniae.

Community prescribing and resistant Streptococcus pneumoniae.

http://www.wikidata.org/entity/Q36009361

about

Origin and proliferation of multiple-drug resistance in bacterial pathogens Patterns of antibacterial use and impact of age, race/ethnicity, and geographic region on antibacterial use in an outpatient medicaid cohort Treatment cost effectiveness in acute otitis media: A watch-and-wait approach versus amoxicillin Comparative analysis of quinolone resistance in clinical isolates of Klebsiella pneumoniae and Escherichia coli from Chinese children and adults.Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.Prevalence of Streptococcus pneumoniae in respiratory samples from patients with tracheostomy in a long-term-care facility No detection of macrolide-resistant Mycoplasma pneumoniae from Swedish patients, 1996-2013.Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy?Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.Entangled Bodies: Jews, Bedouins, and the Making of the Secular Israeli.Long-term effects of penicillin resistance and fitness cost on pneumococcal transmission dynamics in a developed setting.Otitis media with effusion in Lebanese children: prevalence and pathogen susceptibility.Infants under two months of age with urinary tract infections are showing increasing resistance to empirical and oral antibiotics.Antibiotic resistance of Helicobacter pylori in Israeli children.Trends in resistance to penicillin and erythromycin of invasive pneumococci in Portugal.The bla(CTX-M) gene independently enhances drug resistance level to ampicillin in clinical isolates of Klebsiella pneumoniae.Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017.Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.An evolutionary model to predict the frequency of antibiotic resistance under seasonal antibiotic use, and an application to Streptococcus pneumoniae.Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study

P2860

Q27023284-6E1B2243-B531-4603-B0D1-FFC4A07C5000 Q33849251-9A21042E-2DB8-4465-A143-B725555AC9D0 Q34169314-3AFE5517-9C0B-4E62-B375-6E77864DD0B1 Q35113712-AC7C24EF-E961-40FF-9E5C-9195EB0D7DB6 Q35127877-E5BEBBB1-D57F-4B9C-BFF5-119F11B0559D Q36276984-2BA7F082-6553-4281-BFB0-0A2BDBDCDB21 Q36965933-3AA6534E-A25E-4F1F-ABA9-A759B8FD0D22 Q37120857-906F6361-1A5A-4BEA-95EA-17FABE848D42 Q37315289-4A904D9C-8C97-4064-B06E-8B4E00C2F886 Q37959271-35FC2223-5A91-4FA4-9C1A-049E570E8087 Q38382600-A4D3033E-D78F-43E1-A666-724FAF1A0020 Q38864607-2118EEF1-B459-464C-A05A-62278B62D044 Q39295183-0B15104F-64A5-41D4-B322-221013F23E7B Q40165860-469B3904-47F8-4B92-B086-4BD1CD5B0451 Q43144114-DD2F7886-0E50-4B6D-8224-F30E97A99FB0 Q43658970-3013B83B-9F72-4E4C-AF55-B42DF8B9B0B2 Q43904877-1D44147B-4DEC-44A6-B650-89835A3CD148 Q47627293-DEDFB73C-3731-488E-A549-E833843CD173 Q51169250-9FD9D2B7-46DE-40DB-A1A3-7D4D7849A628 Q51203853-7E0EA44D-1A0B-4ABD-881C-990376E005EA Q56935029-0F37333D-F2E7-4100-ACE3-604C0ED5588B

P2860

Community prescribing and resistant Streptococcus pneumoniae.

http://www.wikidata.org/entity/Q36009361

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Community prescribing and resistant Streptococcus pneumoniae.

@ast

Community prescribing and resistant Streptococcus pneumoniae.

@en

type

label

Community prescribing and resistant Streptococcus pneumoniae.

@ast

Community prescribing and resistant Streptococcus pneumoniae.

@en

prefLabel

Community prescribing and resistant Streptococcus pneumoniae.

@ast

Community prescribing and resistant Streptococcus pneumoniae.

@en

P1433

Q36009361-53F44099-C78A-439C-B557-7424EE8B898C

P1476

Q36009361-D9237EEC-880C-40E2-9B8D-3AA713A2ED05

P2093

Q36009361-1A2F83B0-3F64-4E89-8D0C-53306BD6A258

Q36009361-4E6AB954-823F-4146-ACCC-991107BF76A8

Q36009361-6ABF1E39-E96B-443D-8CFF-119495396628

Q36009361-81679440-7BC5-4BD4-A4FC-4DD9E9564E2F

Q36009361-88185DAE-95E7-4578-988C-41E20F3DDBFF

Q36009361-BDC60D2E-E147-426D-ACE7-CCA30B6ADD3D

P2860

Q36009361-0055AEF2-1405-4CCD-A968-522B7E3D9C4C

Q36009361-0C4E1341-3B92-413C-9927-2699AEC36091

Q36009361-17009FF1-D672-4D60-BC17-252B7D170CBC

Q36009361-20E34EEF-DE71-4714-ADC3-CAD6E5A5C782

Q36009361-213069D8-FA8E-4ECE-8D48-E51E6928DF68

Q36009361-225B1298-9BC7-42A4-9960-12463657640F

Q36009361-269D2EE9-AD07-4141-8780-2A656AB7188B

Q36009361-280E2482-1FFB-4175-9A4B-37BDB330588C

Q36009361-2827EC65-9144-400B-B8A8-7E12C242697A

Q36009361-2D89CAE3-242D-4597-9186-50A177A35510

P304

Q36009361-EF40C4AA-9641-41D7-B0D6-0A96E5471B87

P31

Q36009361-209D9AEB-0439-47C9-9B00-C35946A81DB2

P356

Q36009361-9BCBB7AF-D316-4CA0-A52A-3A4D6167CA27

P433

Q36009361-43B2C4CD-EFC9-4D09-B9FF-A8D0AD79DABC

P478

Q36009361-AB869A42-6696-4877-9F65-44663F4965C6

P50

Q36009361-E407F65F-05C6-43DE-80CE-2BA3AA752E35

P577

Q36009361-A9C24296-AC86-4C36-8A79-6CDBD436C4B7

P5875

Q36009361-12BF434C-2836-4565-B461-25FBC584FB4F

P698

Q36009361-A9DCD700-375A-4EEC-AC2C-BB545912E254

P932

Q36009361-03B7B497-72BF-4CCE-9E85-4D4E100A894F

P356

P1433

Emerging Infectious Diseases

P1476

Community prescribing and resistant Streptococcus pneumoniae.

@en

P2093

Daniel Vardy

http://www.w3.org/2001/XMLSchema#string

David Greenberg

http://www.w3.org/2001/XMLSchema#string

Eli Dreifuss

http://www.w3.org/2001/XMLSchema#string

Galia Barkai

http://www.w3.org/2001/XMLSchema#string

Noga Givon-Lavi

http://www.w3.org/2001/XMLSchema#string

Ron Dagan

http://www.w3.org/2001/XMLSchema#string

P2860

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes

Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective

Clinical implications of antibiotic resistance for management of acute otitis media.

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.

Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media.

Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae.

Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain.

Treatment of acute otitis media - challenges in the era of antibiotic resistance.

A European study on the relationship between antimicrobial use and antimicrobial resistance.

P304

829-837

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1106.050198

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Noga Givon-Lavi

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7780655

http://www.w3.org/2001/XMLSchema#string

P698

15963276

http://www.w3.org/2001/XMLSchema#string

P932

3367585

http://www.w3.org/2001/XMLSchema#string